NCT04324424View on ClinicalTrials.gov

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

HMS5552

single dose of HMS5552 25mg

Trial Locations (1)

610000

West China Hospital of Sichuan University, Chengdu

Sponsors
All Listed Sponsors
lead

Hua Medicine Limited

INDUSTRY

NCT04324424 - A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers | Biotech Hunter | Biotech Hunter